Hypogonadism epidemiology and demographics

	Hypogonadism Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hypogonadism from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
X ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hypogonadism epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hypogonadism epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hypogonadism epidemiology and demographics
CDC on Hypogonadism epidemiology and demographics
Hypogonadism epidemiology and demographics in the news
Blogs on Hypogonadism epidemiology and demographics
Directions to Hospitals Treating Hypogonadism
Risk calculators and risk factors for Hypogonadism epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]

Overview

The prevalence of hypogonadism in men is estimated to be 38,700 per 100,000 individual aging 45 years. The incidence of hypogonadism is 1230 per 100,000 persons. Hypogonadism affects men more than women and its prevalence increases with age.^[1]

Epidemiology and demographics

Prevalence

The prevalence of hypogonadism in men is 38,700 per 100,000 persons aged 45 years.^[2]
The prevalence of androgen deficiency ranges from a low of 6,000 per 100,000 persons aged 40 years to a high of 12,000 per 100,000 persons aging 70 years.^[1]
There are no sufficient prevalence results for hypogonadism in women.

Incidence

The incidence of hypogonadism is 1230 per 100,000 persons.^[1] The rate may be increasing^[3]^[4].

Gender

Hypogonadism is more common in the males than females.

Age

The prevalence of hypogonadism increases with age.

Race

There is no racial predilection of hypogonadism.

References

↑ ^1.0 ^1.1 ^1.2 Araujo AB, O'Donnell AB, Brambilla DJ, Simpson WB, Longcope C, Matsumoto AM; et al. (2004). "Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study". J Clin Endocrinol Metab. 89 (12): 5920–6. doi:10.1210/jc.2003-031719. PMID 15579737.
↑ Mulligan T, Frick MF, Zuraw QC, Stemhagen A, McWhirter C (2006). "Prevalence of hypogonadism in males aged at least 45 years: the HIM study". Int J Clin Pract. 60 (7): 762–9. doi:10.1111/j.1742-1241.2006.00992.x. PMC 1569444. PMID 16846397.
↑ Bhasin S (2007). "Secular decline in male reproductive function: Is manliness threatened?". J Clin Endocrinol Metab. 92 (1): 44–5. doi:10.1210/jc.2006-2438. PMID 17209224.
↑ Lokeshwar SD, Patel P, Fantus RJ, Halpern J, Chang C, Kargi AY; et al. (2021). "Decline in Serum Testosterone Levels Among Adolescent and Young Adult Men in the USA". Eur Urol Focus. 7 (4): 886–889. doi:10.1016/j.euf.2020.02.006. PMID 32081788 Check |pmid= value (help).

Template:WH Template:WS

[pmid15579737-1] 1.0 ^1.1 ^1.2 Araujo AB, O'Donnell AB, Brambilla DJ, Simpson WB, Longcope C, Matsumoto AM; et al. (2004). "Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study". J Clin Endocrinol Metab. 89 (12): 5920–6. doi:10.1210/jc.2003-031719. PMID 15579737.

[pmid16846397-2] Mulligan T, Frick MF, Zuraw QC, Stemhagen A, McWhirter C (2006). "Prevalence of hypogonadism in males aged at least 45 years: the HIM study". Int J Clin Pract. 60 (7): 762–9. doi:10.1111/j.1742-1241.2006.00992.x. PMC 1569444. PMID 16846397.

[pmid17209224-3] Bhasin S (2007). "Secular decline in male reproductive function: Is manliness threatened?". J Clin Endocrinol Metab. 92 (1): 44–5. doi:10.1210/jc.2006-2438. PMID 17209224.

[pmid32081788-4] Lokeshwar SD, Patel P, Fantus RJ, Halpern J, Chang C, Kargi AY; et al. (2021). "Decline in Serum Testosterone Levels Among Adolescent and Young Adult Men in the USA". Eur Urol Focus. 7 (4): 886–889. doi:10.1016/j.euf.2020.02.006. PMID 32081788 Check |pmid= value (help).

[1]

[2]

[3]

[4]